<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01180517</url>
  </required_header>
  <id_info>
    <org_study_id>AAG-G-H-1003</org_study_id>
    <nct_id>NCT01180517</nct_id>
  </id_info>
  <brief_title>The Paclitaxel-Eluting Percutaneous Coronary Angioplasty (PTCA)-Balloon Catheter for the Treatment of Coronary Bifurcations</brief_title>
  <acronym>PEPCAD-BIF</acronym>
  <official_title>The Paclitaxel-Eluting PTCA-Balloon Catheter for the Treatment of Coronary Bifurcations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ralf Degenhardt, PhD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>B. Braun Melsungen AG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Heart Centre Rotenburg</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The intention of this trial is to assess the safety and efficacy of Drug Eluting Balloon
      (DEB) application (SeQuent Please) to the side branch in percutaneous coronary intervention
      (PCI) of Medina 0,0,1 coronary bifurcation lesions. Patients will be randomized to treatment
      with Plain Old Balloon Angioplasty (POBA)or treatment with DEB.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>In-segment late lumen loss in the side branch at 9 months</measure>
    <time_frame>9 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Angioplasty</condition>
  <arm_group>
    <arm_group_label>Drug Eluting Balloon</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Plain Old Balloon Angioplasty (POBA)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutaneous coronary intervention (PCI)</intervention_name>
    <description>balloon angioplasty</description>
    <arm_group_label>Drug Eluting Balloon</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PCI</intervention_name>
    <description>balloon angioplasty</description>
    <arm_group_label>Plain Old Balloon Angioplasty (POBA)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria (main):

          -  De-novo Medina type 0,0,1 bifurcational native coronary artery lesion (reference
             diameter:&gt;2.0 mm &lt;3.5 mm, length of stenosis: ≤ 10 mm), the diameter of the side
             branch shall be smaller or equal to the diameter of the distal end vessel

        Exclusion Criteria (main):

          -  Reference side branch diameter &gt; 3.5 mm

          -  Evidence of extensive thrombosis within target vessel

          -  Patients with another coronary stent implanted previously into the target branch or
             bifurcation ≤ 15 mm distant to the current lesion, drug eluting stents less than 9
             months and bare metal stents or stents with passive coatings less than 3 months before
             the PEPCAD- BIF
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>F. X. Kleber, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum Ernst von Bergmann Potsdam, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Herzzentrum Dresden</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Ernst von Bergmann</name>
      <address>
        <city>Potsdam</city>
        <zip>14467</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 9, 2010</study_first_submitted>
  <study_first_submitted_qc>August 11, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 12, 2010</study_first_posted>
  <last_update_submitted>February 18, 2016</last_update_submitted>
  <last_update_submitted_qc>February 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Heart Centre Rotenburg</investigator_affiliation>
    <investigator_full_name>Ralf Degenhardt, PhD</investigator_full_name>
    <investigator_title>Data Manager</investigator_title>
  </responsible_party>
  <keyword>Angioplasty Balloon</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paclitaxel</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

